Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF and Emtricitabine for COVID-19
NCT04712357Unknown
- Sponsor
- Federal University of Ceará
- Start
- Nov 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Placebo, TDF and TDF + FTC (3 arms). Primary endpoint: Time to recovery at Day 7. Status: unknown.
02
Drugs
tenofovir disoproxil fumarateemtricitabine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04712357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04712357.